Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB) recently announced its financial results for the quarter ended September 30, 2024. The clinical-stage pharmaceutical company, focused on developing innova…